Neurogastrx, Inc.

Calculating rank

USPTO Granted Patents = 7

EPO Patents = 1

Forward Citations = 20

Loading Chart...

4 inventors (with patents filed for the assignee):

Cyril De Colle (4 out of 4 patents)

Pankaj Jay Pasricha (4 out of 65 patents)

Shu Yu (3 out of 3 patents)

4. David Juergen Wustrow (1 out of 29 patents)

7 patents: Sort by Forward Citations

1. 11834445 - Polymorphic forms of metopimazine (2023-12-05),

2. 11390620 - Polymorphic forms of metopimazine (2022-07-19),

3. 11147820 - Methods for treating GI tract disorders (2021-10-19),

4. 10836757 - Polymorphic forms of metopimazine (2020-11-17),

5. 9844554 - Prodrugs of metopimazine (2017-12-19),

6. 9808467 - Methods for treating GI tract disorders (2017-11-07),

7. 9132134 - Methods for treating GI tract disorders (2015-09-15),

Company Overview

Neurogastrx, Inc. is a biotechnology company focused on developing innovative treatments for gastrointestinal disorders. With a strong emphasis on neuroenteric science, Neurogastrx is dedicated to improving the lives of patients suffering from conditions such as irritable bowel syndrome and gastroparesis. Through cutting-edge research and development, the company aims to provide novel therapies that address the underlying causes of these debilitating diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

7 Patents

#81 in Woburn, MA

#2,308 in Massachusetts

#39,974 in US

Woburn, MA, United States of America

Neurogastrx, Inc.

Forward Citations = 20

4 inventors:

Cyril De Colle (4 out of 4 patents)

Pankaj Jay Pasricha (4 out of 65 patents)

Shu Yu (3 out of 3 patents)

4. David Juergen Wustrow (1 out of 29 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neurogastrx, Inc.. Retrieved from https://idiyas.com/company/neurogastrx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]